Carolinas Medical Center, Department of Emergency Medicine, Charlotte, NC, USA.
Resuscitation. 2011 Jan;82(1):21-5. doi: 10.1016/j.resuscitation.2010.09.473. Epub 2010 Oct 30.
Therapeutic hypothermia has been shown to improve both mortality and neurologic outcomes following pulseless ventricular tachycardia and fibrillation. Animal data suggest intra-arrest induction of therapeutic hypothermia (IATH) improves frequency of return of spontaneous circulation (ROSC). Our objective was to evaluate the association between IATH and ROSC.
This was a retrospective analysis of individuals experiencing non-traumatic cardiac arrest in a large metropolitan area during a 12-month period. Six months into the study a prehospital IATH protocol was instituted whereby patients received 2000ml of 4°C normal saline directly after obtaining IV/IO access. The main outcome variables were prehospital ROSC, survival to admission, and to discharge. A secondary analysis was conducted to assess the relationship between the quantity of cold saline infused and the likelihood of prehospital ROSC.
551 patients met inclusion criteria with all the elements available for data analysis. Rates of prehospital ROSC were 36.5% versus 26.9% (OR 1.83; 95% CI 1.19-2.81) in patients who received IATH versus normothermic resuscitation respectively. While the frequency of survival to hospital admission and discharge were increased among those receiving IATH, the differences did not reach statistical significance. The secondary analysis found a linear association between the amount of cold saline infused and the likelihood of prehospital ROSC.
The infusion of 4°C normal saline during the intra-arrest period may improve rate of ROSC even at low fluid volumes. Further study is required to determine if intra-arrest cooling has a beneficial effect on rates of ROSC, mortality, and neurologic function.
研究表明,心脏骤停后无脉性室性心动过速和心室颤动患者进行治疗性低温可改善死亡率和神经功能预后。动物研究数据表明,心脏骤停期间的即刻诱导治疗性低温(IATH)可提高自主循环恢复(ROSC)的频率。我们的目的是评估 IATH 与 ROSC 之间的关联。
这是一项对在 12 个月期间在一个大都市区经历非创伤性心脏骤停的个体进行的回顾性分析。在研究进行到 6 个月时,建立了院前 IATH 方案,即患者在获得 IV/IO 通路后立即输注 2000ml 4°C 生理盐水。主要结局变量为院前 ROSC、入院存活率和出院存活率。进行了二次分析,以评估输注冷生理盐水的量与院前 ROSC 可能性之间的关系。
551 名患者符合纳入标准,所有数据均可用于数据分析。与接受常规体温复苏的患者相比,接受 IATH 的患者院前 ROSC 率分别为 36.5%和 26.9%(OR 1.83;95% CI 1.19-2.81)。尽管接受 IATH 的患者入院存活率和出院存活率有所增加,但差异无统计学意义。二次分析发现,输注的冷生理盐水量与院前 ROSC 的可能性呈线性关联。
在心脏骤停期间输注 4°C 生理盐水可能会提高 ROSC 率,即使在低液体量下也是如此。需要进一步研究以确定心脏骤停期间的冷却是否对 ROSC、死亡率和神经功能有有益的影响。